Journal of Crohns & Colitis

Scope & Guideline

Advancing knowledge in inflammatory bowel diseases.

Introduction

Welcome to your portal for understanding Journal of Crohns & Colitis, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1873-9946
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationJ CROHNS COLITIS / J. Crohns Colitis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The Journal of Crohns & Colitis aims to advance the understanding and management of inflammatory bowel diseases (IBD), particularly Crohn's disease and ulcerative colitis. The journal serves as a platform for disseminating high-quality research that spans clinical, translational, and basic science relevant to IBD.
  1. Clinical Research and Trials:
    The journal publishes findings from clinical trials and observational studies that explore the efficacy and safety of various treatment modalities, including biologics and small molecules.
  2. Pathophysiology and Disease Mechanisms:
    Research focusing on the underlying mechanisms of IBD, including genetic, immunological, and microbiological factors that contribute to disease onset and progression.
  3. Diagnostic Innovations:
    Studies on new diagnostic tools, such as imaging techniques and biomarkers, aimed at improving early detection and disease monitoring.
  4. Nutritional and Dietary Interventions:
    Exploration of how dietary patterns and nutritional interventions influence disease activity and patient outcomes in IBD.
  5. Quality of Life and Patient-Centered Care:
    Research addressing the psychosocial aspects of IBD, including quality of life, mental health, and the impact of the disease on daily living.
  6. Epidemiology and Health Services Research:
    Studies that investigate the epidemiology of IBD, healthcare utilization, and disparities in access to treatment.
Recent publications in the Journal of Crohns & Colitis reflect emerging trends and themes that highlight the evolving landscape of research in inflammatory bowel disease. These areas are gaining traction and are likely to shape future studies.
  1. Microbiome Research:
    There is a notable increase in studies exploring the gut microbiota's role in IBD pathogenesis, treatment response, and disease management, indicating a shift towards personalized medicine approaches.
  2. Biologic and Small Molecule Therapies:
    Research on newer biologics and JAK inhibitors is on the rise, reflecting their growing importance in treatment protocols for IBD, particularly in refractory cases.
  3. Digital Health and Telemedicine:
    The integration of digital health tools and telemedicine in managing IBD has gained momentum, especially in light of the COVID-19 pandemic, highlighting patient-centered approaches to care.
  4. Real-World Evidence Studies:
    An increasing number of publications are focused on real-world data and observational studies to assess the effectiveness and safety of treatments in diverse patient populations.
  5. Patient-Reported Outcomes and Quality of Life:
    There is a growing emphasis on understanding the patient's perspective, including the impact of IBD on quality of life and mental health, as well as the importance of shared decision-making in treatment.

Declining or Waning

While the Journal of Crohns & Colitis has consistently focused on advancing research in various aspects of inflammatory bowel disease, certain themes appear to be declining in prominence based on recent publications.
  1. Traditional Pharmacotherapy:
    Research on older pharmacological treatments, such as 5-aminosalicylic acids and thiopurines, has decreased in frequency, likely due to the increasing focus on biologics and novel therapies.
  2. Surgical Approaches:
    While surgical management remains important, the volume of studies solely focused on surgical techniques without integration into broader treatment paradigms has diminished, as there is a shift towards understanding IBD as a chronic disease needing multidisciplinary management.
  3. Animal Models of IBD:
    The reliance on animal models for studying IBD mechanisms may be waning as there is a growing emphasis on human-derived data and translational research that directly informs clinical practice.

Similar Journals

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Transforming understanding of gastroenterology and hepatology.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Canadian Journal of Gastroenterology and Hepatology

Elevating Standards in Gastroenterology and Hepatology Research
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

United European Gastroenterology Journal

Bridging research and practice for clinical excellence.
Publisher: JOHN WILEY & SONS LTDISSN: 2050-6406Frequency: 6 issues/year

The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.

JOURNAL OF GASTROENTEROLOGY

Leading the way in gastroenterology research excellence.
Publisher: SPRINGER JAPAN KKISSN: 0944-1174Frequency: 12 issues/year

JOURNAL OF GASTROENTEROLOGY, published by SPRINGER JAPAN KK, is a premier academic journal that has been at the forefront of gastrointestinal research since its inception in 1994. With an impressive Impact Factor and ranking in the top quartile (Q1) of its category, this journal holds a significant place in the field of gastroenterology, currently ranked 12th out of 167 in Scopus, placing it in the 93rd percentile. The journal serves as an essential platform for disseminating innovative research, clinical studies, and reviews that foster advancements in the understanding and treatment of gastrointestinal diseases. Although it does not offer Open Access options, it provides researchers, clinicians, and students access to crucial insights and breakthroughs pivotal to improving patient care and outcomes in gastroenterology. With a commitment to high-quality peer-reviewed content, JOURNAL OF GASTROENTEROLOGY plays a vital role in shaping the future of gastrointestinal health and research.

Clinical and Experimental Gastroenterology

Advancing gastrointestinal health through innovative research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Gastrointestinal Disorders

Advancing Gastrointestinal Health Through Open Access Research
Publisher: MDPIISSN: Frequency: 4 issues/year

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Advancing pediatric health through nutrition and gastrointestinal research.
Publisher: WILEYISSN: 0277-2116Frequency: 12 issues/year

Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.

Translational Gastroenterology and Hepatology

Unlocking Innovations for Liver and Gut Health.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

PRACTICAL GASTROENTEROLOGY

Advancing Gastrointestinal Insights for Practitioners
Publisher: SHUGAR PUBLISHING INCISSN: 0277-4208Frequency: 12 issues/year

PRACTICAL GASTROENTEROLOGY is a distinguished journal dedicated to the field of gastroenterology, published by Shugar Publishing Inc in the United States. With an ISSN of 0277-4208, the journal serves as a pivotal resource for medical professionals, researchers, and students keen on staying abreast of the latest advancements and practical applications in gastrointestinal health. Although it does not currently operate under an Open Access model, it has been a respected publication since its inception, spanning significant years of research from 1989 to 2013 and resuming again from 2016 to 2023. Despite holding a current Q4 ranking in Gastroenterology with Scopus, its commitment to quality insights provides a platform for critical information dissemination, making it an essential read for those engaged in clinical practice and academic research. The journal’s objectives include addressing practical challenges in gastroenterology, bridging the gap between research and clinical implementation, and fostering ongoing education among practitioners in this dynamic field.

BMJ Open Gastroenterology

Connecting Researchers for a Healthier Gastrointestinal Future
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.